Gallery

Merrion Pharmaceuticals Official Opening of their new facility Pictured L to R: Paddy O'Sullivan, Chairman, Merrion Pharmaceuticals, Mary Harney T.D., Minister for Health & Children and John Lynch, CEO, Merrion Pharmaceuticals at the official opening of Merrion's new facility. Download: low res (161KB) \| high res (598KB)

Merrion Pharmaceuticals Official Opening of their new facility Merrion Pharmaceuticals Team at the Official Opening Ceremony. Download: low res (188KB) \| high res (638KB)

Merrion Pharmaceuticals Official Opening of their new facility Pictured L to R: John Lynch, CEO, Merrion Pharmaceuticals and Mary Harney T.D., Minister for Health & Children in the laboratories of Merrion's new facility. Download: low res (118KB) \| high res (501KB)

Merrion Pharmaceuticals Official Opening of their new facility Pictured L to R: John Lynch, CEO, Merrion Pharmaceuticals and Paddy O'Sullivan, Chairman, Merrion Pharmaceuticals at the opening of the new facility. Download: low res (228KB) \| high res (831KB)

Merrion Announces License Agreement with Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonist(s) - Novo Nordisk makes equity investment in Merrion 16th January 2009 John Lynch, CEO of Merrion Pharmaceuticals at the announcement today (16th January 2009) of Merrion's second $58m contract with Novo Nordisk.

Merrion Announces License Agreement with Novo Nordisk to Develop Oral Formulation of Insulin Analogues Minister for Enterprise, Trade and Employment, Mary Coughlan, T.D. with John Lynch, CEO of Merrion Pharmaceuticals at the announcement today (Monday 24th November 2008) of Merrion's $58m contract with Novo Nordisk. Download: low res (329KB) \| high res (1.20MB)

Merrion Pharmaceuticals Official Opening of their new facility Pictured L to R: Paddy O'Sullivan, Chairman, Merrion Pharmaceuticals, Mary Harney T.D., Minister for Health & Children and John Lynch, CEO, Merrion Pharmaceuticals at the official opening of Merrion's new facility. Download: low res (161KB) \| high res (598KB)

Merrion Pharmaceuticals Official Opening of their new facility Merrion Pharmaceuticals Team at the Official Opening Ceremony. Download: low res (188KB) \| high res (638KB)

Merrion Pharmaceuticals Official Opening of their new facility Pictured L to R: John Lynch, CEO, Merrion Pharmaceuticals and Mary Harney T.D., Minister for Health & Children in the laboratories of Merrion's new facility. Download: low res (118KB) \| high res (501KB)

Merrion Pharmaceuticals Official Opening of their new facility Pictured L to R: John Lynch, CEO, Merrion Pharmaceuticals and Paddy O'Sullivan, Chairman, Merrion Pharmaceuticals at the opening of the new facility. Download: low res (228KB) \| high res (831KB)

Merrion Announces License Agreement with Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonist(s) - Novo Nordisk makes equity investment in Merrion 16th January 2009 John Lynch, CEO of Merrion Pharmaceuticals at the announcement today (16th January 2009) of Merrion's second $58m contract with Novo Nordisk.

Merrion Announces License Agreement with Novo Nordisk to Develop Oral Formulation of Insulin Analogues Minister for Enterprise, Trade and Employment, Mary Coughlan, T.D. with John Lynch, CEO of Merrion Pharmaceuticals at the announcement today (Monday 24th November 2008) of Merrion's $58m contract with Novo Nordisk. Download: low res (329KB) \| high res (1.20MB)